1 – 20 of 112
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
- 2023
-
Mark
Acute pancreatitis–one key to early detection of pancreatic cancer?
2023) In Scandinavian Journal of Gastroenterology(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
-
Mark
Microbiome alterations in pancreatic cancer : new insights and potential clinical implications
2023) In Scandinavian Journal of Gastroenterology(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Histopathological investigation of colon liver metastases–which factors affect survival after surgery?
(
- Contribution to journal › Article
- 2022
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
(
- Contribution to journal › Article
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IPMN of the pancreas–does histological subtyping allow for improved stratification and follow-up?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–can evidence-based guidelines be transferred to an optimized comprehensive treatment program?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
- 2020
-
Mark
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
(
- Contribution to journal › Article
-
Mark
Re-resection for incidentally detected gallbladder cancer : Weighing in on the options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Blood-based markers for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas–what’s beyond the horizon?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
- 2019
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
(
- Contribution to journal › Article
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial